Survival Disparities by Insurance Type for Patients Aged 15-64 Years With Non-Hodgkin Lymphoma

Oncologist - United States
doi 10.1634/theoncologist.2014-0386
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Alphamed Press

Related search

Non-Hodgkin Lymphoma

2020English

Venetoclax (Ven) in Patients With Relapsed/Refractory Non-Hodgkin Lymphoma (Nhl)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Epidemiology of Chemotherapy-Induced Anemia in Patients With Non-Hodgkin Lymphoma

Permanente journal,The
Medicine
2019English

Potentially Inappropriate Medication Use in Elderly Non-Hodgkin Lymphoma Patients Is Associated With Reduced Survival and Increased Toxicities

British Journal of Haematology
Hematology
2017English

The Influence of Marital Status on the Survival of Patients With Hodgkin Lymphoma

Oncotarget
Oncology
2017English

Pre-Diagnosis Cigarette Smoking and Overall Survival in Non-Hodgkin Lymphoma

British Journal of Haematology
Hematology
2013English

Stage I Non-Hodgkin Lymphoma: Difference in Survival Outcome by Primary Extranodal Site of Involvement

British Journal of Haematology
Hematology
2018English

Novel Treatment Strategies for Patients With Relapsed Classical Hodgkin Lymphoma

Blood Reviews
OncologyHematology
2010English

Prognostic Factors in HIV-positive Patients With Non-Hodgkin Lymphoma: A Peruvian Experience

Infectious Agents and Cancer
Cancer ResearchEpidemiologyOncologyInfectious Diseases
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy